These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 29102563)
21. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin. Meng XM; Zhang Y; Huang XR; Ren GL; Li J; Lan HY Oncotarget; 2015 Nov; 6(35):36984-97. PubMed ID: 26474462 [TBL] [Abstract][Full Text] [Related]
22. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750 [TBL] [Abstract][Full Text] [Related]
23. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta and Smad signalling in kidney diseases. Wang W; Koka V; Lan HY Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182 [TBL] [Abstract][Full Text] [Related]
25. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Zhou Q; Chung AC; Huang XR; Dong Y; Yu X; Lan HY Am J Pathol; 2014 Feb; 184(2):409-17. PubMed ID: 24262754 [TBL] [Abstract][Full Text] [Related]
26. Response gene to complement 32 is essential for fibroblast activation in renal fibrosis. Li Z; Xie WB; Escano CS; Asico LD; Xie Q; Jose PA; Chen SY J Biol Chem; 2011 Dec; 286(48):41323-41330. PubMed ID: 21990365 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation. Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202 [TBL] [Abstract][Full Text] [Related]
28. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222 [TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs. Tang PM; Zhang YY; Mak TS; Tang PC; Huang XR; Lan HY J Physiol; 2018 Aug; 596(16):3493-3503. PubMed ID: 29781524 [TBL] [Abstract][Full Text] [Related]
30. Defect in Runx2 gene accelerates ureteral obstruction-induced kidney fibrosis via increased TGF-β signaling pathway. Kim JI; Jang HS; Jeong JH; Noh MR; Choi JY; Park KM Biochim Biophys Acta; 2013 Oct; 1832(10):1520-7. PubMed ID: 23639629 [TBL] [Abstract][Full Text] [Related]
31. HGF alleviates renal interstitial fibrosis via inhibiting the TGF-β1/SMAD pathway. Xu J; Yu TT; Zhang K; Li M; Shi HJ; Meng XJ; Zhu LS; Zhu LK Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7621-7627. PubMed ID: 30536302 [TBL] [Abstract][Full Text] [Related]
32. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling. Zhu Y; Yu C; Zhuang S Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251 [TBL] [Abstract][Full Text] [Related]
33. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy. Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342 [TBL] [Abstract][Full Text] [Related]
34. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation. Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068 [TBL] [Abstract][Full Text] [Related]
35. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. Chung AC; Huang XR; Meng X; Lan HY J Am Soc Nephrol; 2010 Aug; 21(8):1317-25. PubMed ID: 20488955 [TBL] [Abstract][Full Text] [Related]
36. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice. Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086 [TBL] [Abstract][Full Text] [Related]
37. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling. Zhang Y; Meng XM; Huang XR; Lan HY Clin Sci (Lond); 2018 Jul; 132(13):1403-1415. PubMed ID: 29875262 [TBL] [Abstract][Full Text] [Related]
38. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
39. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250 [TBL] [Abstract][Full Text] [Related]
40. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3. Tian F; Zhang ZY; Sun J; Han YC Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):787-794. PubMed ID: 33577033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]